Norwalk Leslie V

CIK 000153356811 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001533568

Recent Transactions

50 trades

Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-12-16$155.09/sh−1,190→ 6,239 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-12-15−8,276→ 557 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-12-15$152.23/sh−5,000→ 7,429 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-12-15−1,724→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-12-15$84.95/sh+1,724→ 12,429 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-12-15$92.35/sh+8,276→ 10,705 total
Sale
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2025-12-12$88.85/sh−4,000→ 12,419 total
Award
CVS HEALTH Corp$CVS
Common Stock
2025-11-20$76.04/sh+1,652→ 5,929 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2025-06-25+23,105→ 23,105 total
Award
ARVINAS, INC.$ARVN
Common Stock
2025-06-25+16,025→ 26,045 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-22+1,435→ 2,429 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-22−1,435→ 0 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-05-21+3,305→ 3,305 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-21+1,659→ 1,659 total
Award
CVS HEALTH Corp$CVS
Common Stock
2025-05-15$60.47/sh+2,077→ 4,277 total
Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2025-01-23+15,000→ 15,000 total
Award
CVS HEALTH Corp$CVS
Common Stock
2024-11-21$57.10/sh+2,200→ 2,200 total
Sale
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2024-07-11$70.00/sh−1,000→ 16,419 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2024-05-29+9,070→ 9,070 total
Award
ARVINAS, INC.$ARVN
Common Stock
2024-05-29+5,899→ 10,020 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-22+2,982→ 2,982 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-22+1,435→ 1,435 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17+2,100→ 2,100 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17$141.82/sh−1,106→ 994 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-17−2,100→ 0 total
Sale
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2024-03-15$51.99/sh−10,590→ 17,419 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-27$84.95/sh+8,000→ 8,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-27$135.67/sh−8,000→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-02-27$84.95/sh−8,000→ 1,724 total
Award
ModivCare Inc$MODVQ
Common Stock
2024-02-14+2,658→ 18,830 total
Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2024-01-26+15,000→ 15,000 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−3,788→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−3,230→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−2,130→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−2,822→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−3,725→ 0 total
Disposition to Issuer
NUVASIVE INC
Common Stock, par value $0.001 per share
2023-09-01−3,095→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−2,702→ 0 total
Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2023-09-01+15,000→ 15,000 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−2,577→ 0 total
Award
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2023-09-01+25,688→ 28,009 total
Award
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2023-09-01+2,321→ 2,321 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−2,501→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−5,960→ 0 total
Disposition to Issuer
NUVASIVE INC
Restricted Stock
2023-09-01−4,816→ 0 total
Award
ARVINAS, INC.$ARVN
Common Stock
2023-06-15+4,121→ 4,121 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2023-06-15+12,787→ 12,787 total
Award
NUVASIVE INC
RSUs
2023-06-09+4,816→ 4,816 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-05-17+2,100→ 2,100 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-05-17+4,290→ 4,290 total

Norwalk Leslie V

Recent Transactions

Companies

Recent Filings

Address